Pneumonia Therapeutics Market Forecast to 2026 - COVID-19 Impact and Analysis

Global Pneumonia Therapeutics Market worth is expected to reach USD 2.84 billion by 2026 from USD 1.7 billion in 2019 at a CAGR of 7.60% during the projection period.

The worldwide pneumonia therapeutics market is advancing due to the harmful effects of air pollution and rising geriatric populace across the world. Besides, numerous environmental wastes, including chemicals, catalyse the development of fungi, viruses, and bacteria leading to pneumonia. Moreover, the extensive R&D activities for new drugs and diagnostics by major companies and critical unmet need for pneumonia remedies propel the market for pneumonia therapeutics. However, the lack of consciousness among the population about proper drugs and diagnostics and use of traditional treatment for pneumonia may restrain the market growth.